RDN (Radian Group Inc.) Stock Analysis - Financials

Radian Group Inc. (RDN) is a publicly traded Financial Services sector company. As of May 21, 2026, RDN trades at $37.60 with a market cap of $5.03B and a P/E ratio of 9.16. RDN moved +0.90% today. Year to date, RDN is +3.55%; over the trailing twelve months it is +9.65%. Its 52-week range spans $29.32 to $38.84. Analyst consensus is buy with an average price target of $41.80. Rallies surfaces RDN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are RDN's key financials?

RDN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. RDN recently traded at $37.60. Market cap is $5.03B. P/E ratio is 9.16. Revenue is $1.37B.

RDN Key Metrics

Key financial metrics for RDN
MetricValue
Price$37.60
Market Cap$5.03B
P/E Ratio9.16
EPS$4.10
Dividend Yield0.26%
52-Week High$38.84
52-Week Low$29.32
Volume0
Avg Volume0
Revenue (TTM)$1.37B
Net Income$562.17M
Gross Margin0.00%

RDN Annual Financials

YearRevenueNet IncomeEPS
2025$1.20B$618.18M$4.18
2023$1.24B$603.12M$3.81
2022$1.19B$742.93M$4.42
2021$1.33B$600.67M$3.19

Latest RDN News

Recent RDN Insider Trades

  • Hoffman Edward J sold 15.00K (~$570.00K) on May 8, 2026.
  • Hoffman Edward J sold 15.00K (~$555.00K) on Apr 29, 2026.
  • Hoffman Edward J sold 15.00K (~$540.00K) on Apr 23, 2026.

RDN Analyst Consensus

5 analysts cover RDN: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $41.80.

Common questions about RDN

What are RDN's key financials?
RDN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. RDN recently traded at $37.60. Market cap is $5.03B. P/E ratio is 9.16. Revenue is $1.37B.
Is RDN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RDN. It does not provide personalized investment advice.
RDN

RDN